• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AXIN2 多态性与癌症风险和易感性的相关性的新见解:来自 72 项研究的证据。

New insights of the correlation between AXIN2 polymorphism and cancer risk and susceptibility: evidence from 72 studies.

机构信息

Department of Geriatric Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.

出版信息

BMC Cancer. 2021 Apr 1;21(1):353. doi: 10.1186/s12885-021-08092-0.

DOI:10.1186/s12885-021-08092-0
PMID:33794810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8017882/
Abstract

BACKGROUND

Numerous studies have reported the correlation between AXIN2 polymorphism and cancer risk, but the results seem not consistent. In order to get an overall, accurate and updated results about AXIN2 polymorphism and cancer risk, we conducted this study.

METHODS

An updated analysis was performed to analyze the correlation between AXIN2 polymorphisms and cancer risk. Linkage disequilibrium (LD) analysis was also used to show the associations.

RESULTS

Seventy-two case-control studies were involved in the study, including 22,087 cases and 18,846 controls. The overall results showed rs11079571 had significant association with cancer risk (allele contrast model: OR = 0.539, 95%CI = 0.478-0.609, PAdjust = 0.025; homozygote model: OR = 0.22, 95% CI = 0.164-0.295, PAdjust< 0.001; heterozygote model: OR = 0.292, 95% CI = 0.216-0.394, PAdjust< 0.001; dominant model: OR = 0.249, 95% CI = 0.189-0.33, PAdjust< 0.001). The same results were obtained with rs1133683 in homozygote and recessive models (PAdjust< 0.05), and in rs35285779 in heterozygote and dominant models (PAdjust< 0.05). LD analysis revealed significant correlation between rs7210356 and rs9915936 in the populations of CEU, CHB&CHS, ESN and JPT (CEU: r = 0.91; CHB&CHS: r = 0.74; ESN: r = 0.62, JPT: r = 0.57), and a significant correlation between rs9915936 and rs7224837 in the populations of CHB&CHS, ESN and JPT (r>0.5), between rs7224837 and rs7210356 in the populations of CEU, CHB&CHS, JPT (r>0.5), between rs35435678 and rs35285779 in the populations of CEU, CHB&CHS and JPT (r>0.5).

CONCLUSIONS

AXIN2 rs11079571, rs1133683 and rs35285779 polymorphisms have significant correlations with overall cancer risk. What's more, two or more polymorphisms such as rs7210356 and rs9915936, rs9915936 and rs7224837, rs7224837 and rs7210356, rs35435678 and rs35285779 have significant correlation with cancer susceptibility in different populations.

摘要

背景

许多研究报告了 AXIN2 多态性与癌症风险之间的相关性,但结果似乎不一致。为了获得关于 AXIN2 多态性与癌症风险的全面、准确和最新的结果,我们进行了这项研究。

方法

对 AXIN2 多态性与癌症风险的相关性进行了更新的分析。还进行了连锁不平衡(LD)分析以显示相关性。

结果

这项研究共纳入了 72 项病例对照研究,包括 22087 例病例和 18846 例对照。总体结果表明 rs11079571 与癌症风险显著相关(等位基因对比模型:OR=0.539,95%CI=0.478-0.609,PAdjust=0.025;纯合子模型:OR=0.22,95%CI=0.164-0.295,PAdjust<0.001;杂合子模型:OR=0.292,95%CI=0.216-0.394,PAdjust<0.001;显性模型:OR=0.249,95%CI=0.189-0.33,PAdjust<0.001)。在 rs1133683 的纯合子和隐性模型(PAdjust<0.05)以及 rs35285779 的杂合子和显性模型(PAdjust<0.05)中也得到了相同的结果。LD 分析显示,rs7210356 与 rs9915936 之间在 CEU、CHB&CHS、ESN 和 JPT 人群中存在显著相关性(CEU:r=0.91;CHB&CHS:r=0.74;ESN:r=0.62,JPT:r=0.57),rs9915936 与 rs7224837 之间在 CHB&CHS、ESN 和 JPT 人群中存在显著相关性(r>0.5),rs7224837 与 rs7210356 之间在 CEU、CHB&CHS、JPT 人群中存在显著相关性(r>0.5),rs35435678 与 rs35285779 之间在 CEU、CHB&CHS 和 JPT 人群中存在显著相关性(r>0.5)。

结论

AXIN2 rs11079571、rs1133683 和 rs35285779 多态性与总体癌症风险显著相关。此外,rs7210356 和 rs9915936、rs9915936 和 rs7224837、rs7224837 和 rs7210356 等两个或更多多态性与不同人群的癌症易感性存在显著相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/2d92f85dd69a/12885_2021_8092_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/ae2ca91e4a19/12885_2021_8092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/d592f94aa8bd/12885_2021_8092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/c713e5bf4e28/12885_2021_8092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/9af4b69289b6/12885_2021_8092_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/2d92f85dd69a/12885_2021_8092_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/ae2ca91e4a19/12885_2021_8092_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/d592f94aa8bd/12885_2021_8092_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/c713e5bf4e28/12885_2021_8092_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/9af4b69289b6/12885_2021_8092_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91ef/8017882/2d92f85dd69a/12885_2021_8092_Fig5_HTML.jpg

相似文献

1
New insights of the correlation between AXIN2 polymorphism and cancer risk and susceptibility: evidence from 72 studies.AXIN2 多态性与癌症风险和易感性的相关性的新见解:来自 72 项研究的证据。
BMC Cancer. 2021 Apr 1;21(1):353. doi: 10.1186/s12885-021-08092-0.
2
Association of AXIN2 s2240308 C>T, rs1133683 C>T, rs7224837 A>G Polymorphisms with Susceptibility to Breast Cancer.AXIN2 s2240308 C>T、rs1133683 C>T、rs7224837 A>G 多态性与乳腺癌易感性的关联。
Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2717-2722. doi: 10.31557/APJCP.2021.22.8.2717.
3
Polymorphism of MMP-9 gene is not associated with the risk of urinary cancers: Evidence from an updated meta-analysis.基质金属蛋白酶-9(MMP-9)基因多态性与泌尿系统癌症风险无关:一项更新的荟萃分析证据
Pathol Res Pract. 2018 Dec;214(12):1966-1973. doi: 10.1016/j.prp.2018.09.011. Epub 2018 Sep 13.
4
Association of Axis Inhibition Protein 2 Polymorphisms with Non-Syndromic Cleft Lip with or without Cleft Palate in Iranian Children.伊朗儿童中轴抑制蛋白2基因多态性与非综合征性唇裂伴或不伴腭裂的相关性
Fetal Pediatr Pathol. 2020 Feb;39(1):29-37. doi: 10.1080/15513815.2019.1636430. Epub 2019 Jul 3.
5
AXIN2 polymorphism and its association with prostate cancer in a Turkish population.AXIN2 多态性与土耳其人群前列腺癌的关系。
Med Oncol. 2011 Dec;28(4):1373-8. doi: 10.1007/s12032-010-9588-y. Epub 2010 Nov 11.
6
New concept of the Axin2 rs2240308 polymorphism and cancer risk: an updated meta-analysis.Axin2 rs2240308 多态性与癌症风险的新概念:一项更新的荟萃分析。
Neoplasma. 2017;64(2):269-277. doi: 10.4149/neo_2017_214.
7
The association between three AXIN2 variants and cancer risk.AXIN2 三种变异与癌症风险的关联。
J Cell Biochem. 2019 Sep;120(9):15561-15571. doi: 10.1002/jcb.28823. Epub 2019 Apr 30.
8
Quantitative assessment of the association between AXIN2 rs2240308 polymorphism and cancer risk.AXIN2基因rs2240308多态性与癌症风险关联的定量评估。
Sci Rep. 2015 May 14;5:10111. doi: 10.1038/srep10111.
9
AXIN2 Polymorphisms and Their Association with Colorectal Cancer in Mexican Patients.AXIN2基因多态性及其与墨西哥患者结直肠癌的关联。
Genet Test Mol Biomarkers. 2016 Aug;20(8):438-44. doi: 10.1089/gtmb.2016.0026. Epub 2016 May 26.
10
Association of single nucleotide polymorphisms in AXIN2, BMP4, and IRF6 with Non-Syndromic Cleft Lip with or without Cleft Palate in a sample of the southeast Iranian population.AXIN2、BMP4 和 IRF6 单核苷酸多态性与伊朗东南部人群中非综合征性唇裂伴或不伴腭裂的关联。
J Appl Oral Sci. 2017 Nov-Dec;25(6):650-656. doi: 10.1590/1678-7757-2017-0191.

引用本文的文献

1
Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation.癌症中的Wnt信号传导:从生物标志物到靶向治疗及临床转化
Mol Cancer. 2025 Apr 2;24(1):107. doi: 10.1186/s12943-025-02306-w.
2
Predicting Survival Among Colorectal Cancer Patients: Development and Validation of Polygenic Survival Score.预测结直肠癌患者的生存率:多基因生存评分的开发与验证
Clin Exp Gastroenterol. 2024 Oct 14;17:317-329. doi: 10.2147/CEG.S464324. eCollection 2024.
3
"Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.

本文引用的文献

1
Variations in predict risk and prognosis of colorectal cancer.这些变化可预测结直肠癌的风险和预后。
BDJ Open. 2019 Oct 16;5:13. doi: 10.1038/s41405-019-0022-z. eCollection 2019.
2
Genetic variants in the WNT signaling pathway are protectively associated with colorectal cancer in a Saudi population.WNT信号通路中的基因变异与沙特人群的结直肠癌呈保护性关联。
Saudi J Biol Sci. 2019 Feb;26(2):286-293. doi: 10.1016/j.sjbs.2018.05.018. Epub 2018 May 17.
3
New insights into the association between 148 C/T, 1365 C/T, and rs4791171 A/G variants and cancer risk.
探讨先天性牙齿缺失与甲状腺乳头状癌之间的联系:是否存在风险因素? 观察性研究。
Prog Orthod. 2024 Mar 25;25(1):12. doi: 10.1186/s40510-024-00511-9.
4
Association of AXIN2 s2240308 C>T, rs1133683 C>T, rs7224837 A>G Polymorphisms with Susceptibility to Breast Cancer.AXIN2 s2240308 C>T、rs1133683 C>T、rs7224837 A>G 多态性与乳腺癌易感性的关联。
Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2717-2722. doi: 10.31557/APJCP.2021.22.8.2717.
关于148 C/T、1365 C/T和rs4791171 A/G变异与癌症风险之间关联的新见解。
Cancer Cell Int. 2019 May 6;19:119. doi: 10.1186/s12935-019-0840-z. eCollection 2019.
4
The association between three AXIN2 variants and cancer risk.AXIN2 三种变异与癌症风险的关联。
J Cell Biochem. 2019 Sep;120(9):15561-15571. doi: 10.1002/jcb.28823. Epub 2019 Apr 30.
5
TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells.TMEPAI/PMEPA1 通过调节三阴性乳腺癌细胞中β-连环蛋白的稳定性和核积累来抑制 Wnt 信号通路。
Cell Signal. 2019 Jul;59:24-33. doi: 10.1016/j.cellsig.2019.03.016. Epub 2019 Mar 16.
6
MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.miR-454-3p 通过调控 Wnt/β-catenin 信号通路抑制物促进乳腺癌转移。
Theranostics. 2019 Jan 1;9(2):449-465. doi: 10.7150/thno.29055. eCollection 2019.
7
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
8
LncRNA miR143HG suppresses bladder cancer development through inactivating Wnt/β-catenin pathway by modulating miR-1275/AXIN2 axis.长链非编码 RNA miR143HG 通过调节 miR-1275/AXIN2 轴抑制膀胱癌的发展,从而使 Wnt/β-连环蛋白途径失活。
J Cell Physiol. 2019 Jul;234(7):11156-11164. doi: 10.1002/jcp.27764. Epub 2018 Nov 23.
9
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.欧洲癌症发病率和死亡率模式:2018 年 40 个国家和 25 种主要癌症的估计值。
Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9.
10
MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2.miR-183 通过靶向 AXIN2 维持经典 Wnt 信号活性并调节膀胱癌的生长和凋亡。
Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4828-4836. doi: 10.26355/eurrev_201808_15618.